Pharmacology S4 Flashcards

1
Q

Insulin Therapy

Fast acting native insulin

A

Actrapid, Humulin S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Insulin Therapy

Fast acting analogues

A

Novorapid, Humalog

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Intermediate acting native insulin (NPH)

A

Insulatard, Humulin I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Insulin Therapy

Intermediate / long acting analogues

A

Levemir, Glargine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Different Insulin Regimens

Pre-mixed insulin regimen

A

Humalog Mix 25, Novomix 30, Mixtard 30

◼ ◼

Taken twice daily with or before meals Lacks flexibility but only twice per day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Basal Bolus regimen features

A

Intermediate or long acting insulin as background Fast acting insulin with meals Flexible but up to five times per day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Side effects of insulin therapy

A

Hypoglycemia

Lipodystrophy

  1. Allergy
  2. Weight gain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Symptoms of hypoglycemia

A
Headache 
Vertigo 
Diaphoresis
Shaking
Inc appetite
Blurred vision 
Weakness/ fatigue 
Anxiety
Tachycardia 
Confusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Metformin

Action?

A

Decreased hepatic glucose output

mitochondria

Increased glucose uptake in skeletal muscle and fat

GLUT 1 and GLUT 4

Special benefits in overweight patients

Weight-neutral or weight-reducing Improvement in cardiovascular outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Metformin side effect

A

Side effects mitigated by slow dose titration (GI upset)

Usual maximum dose is 1g bd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Metformin contraindicated

A

Contraindicated in metabolic failure (renal failure, hepatic failure and acute heart failure)

Stop before radiocontrast media and surgery

Does not cause hypoglycaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Action of Sulphonylureas

A

Enhances insulin secretion (irrespective of ambient glucose level)

Specific receptor on beta cell Closure of ATP-sensitive potassium channel Influx of calcium and extrusion of secretory granules

Reduces fasting and postprandial glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sulphonylureas half life

Give examples of drug with long Half life& which one is the preferred type of drug

A

Half-life important

Glibenclamide long half life

Can lead to prolonged hypoglycaemia, especially in elderly

Gliclazide short half-life and, therefore, preferred agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sulphonylureas side effect

A

Can cause hypoglycaemia

Associated with weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Repaglinide action

A

Non-sulphonylurea insulin secretagogue Three receptors.

Similar action to sulphonylureas. Identical efficacy

Requires glucose to have effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Repaglinide half life ?

A

Short plasma half-life

0.5mg with meals, max 16 mg/day

Weekly increase in dose if required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Good effect of Repaglinide

A

Weight neutral Less severe hypoglycaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Acarbose action

A

a-glucosidase inhibitor

◼ ◼

Delays absorption of carbohydrates Allows beta-cell time to augment response

Decreases HbA1c by 1%, fpg by 1.5mmol/l No change in weight Modest decrease in triglyceride Dosage schedule

With first bite. Start low, increase every 2 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Acarbose CI

A

Contraindicated in renal failure, IBD & cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

side effects of Acarbose

A

Rarely used owing to poor efficacy and significant GI side effects
Bloating
Constipation
Git distress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Thiazolidenediones actions

A

PPARg-agonists Improve insulin sensitivity

Liver, skeletal muscle and adipocytes

22
Q

Thiazolidenediones side effect

A

Durable effect on glycaemia Associated with weight gain

Part of action of these drugs

23
Q

Thiazolidenediones CI

A

Contraindicated in heart failure

Recent controversy about CV effects and increased risk of bone fractures

24
Q

Pharmacology of Type 2 Diabetes

A

Metformin

🌼
First choice in overweight or obese unless contraindicated

Sulphonylureas and their derivatives Thiazolidinediones

Insulins

Including inhaled insulin (no longer available)

Newer agents

◼ ◼

GLP 1 analogues

GLP 1 is produced by L cells of the small intestine

DPP4 inhibitors

DPP4 is the enzyme that breaks down GLP1

Sodium-glucose transporter inhibitors Colesevelam and bromocriptine

25
Q

GLP1analogues?

A

Exenatide is An injectable GLP1 analogue

26
Q

DPP4 Inhibitors

A

and the gliptins are oral DPP4 inhibitors

27
Q

Adverse effects of GLP-1 analogues

A

All of the GLP-1 receptor agonists may increase the risk of pancreatitis

Cases of renal impairment and acute renal injury have been reported in patients taking exenatide.

Both exenatide and liraglutide stimulate thyroidal C-cell (parafollicular) tumors in rodents.

The drugs, however, should not be used in persons with a past medical or family history of medullary thyroid cancer or multiple endocrine neoplasia (MEN) syndrome type 2

28
Q

GLP-1 analogues CI

A

The drugs, however, should not be used in persons with a past medical or family history of medullary thyroid cancer or multiple endocrine neoplasia (MEN) syndrome type 2

29
Q

SGLT2 inhibitors give examples

A

Canagliflozin and empagliflozin

dapagliflozin

30
Q

SGLT2 inhibitors side effect

A

The osmotic diuresis can also cause intravascular volume contraction and hypotension

Canagliflozin and empagliflozin caused a modest increase in LDL cholesterol levels (4–8%)

In clinical trials patients taking dapagliflozin had higher rates of breast cancer (nine cases versus none in comparator arms) and bladder cancer (nine cases versus one in placebo arm

31
Q

SYNTHETIC AMYLIN ANALOGUE:give E

A

Pramlinitide

32
Q

SYNTHETIC AMYLIN ANALOGUE:

Mechanism

A

Pharmacological effects

◼ ◼ ◼

    1. 3.

Reduces glucagon secretion Slows gastric emptying rate Centrally decreases appetite

33
Q

Bromocriptine adverse events

A

The main adverse events are nausea, fatigue, dizziness, vomiting, and headache

34
Q

mechanisms of dopamine agonist lowering BG level

A

Bromocriptine the dopamine agonist, in randomized placebo-controlled studies lowered HbA1c by 0–0.2% compared with baseline and by 0.4–0.5% compared with placebo. The mechanism by which it lowers glucose levels is not known. The main adverse events are nausea, fatigue, dizziness, vomiting, and headache

35
Q

Obesity Medication

Three specific drugs

A

Orlistat

Gastric and pancreatic lipase inhibitor

Theoretical deficiency of fat soluble vitamins

Sibutramine

Norepinephrine and serotonin reuptake inhibitor

◼ ◼

Contraindicated in depression Blood pressure must be closely monitored

Rimonabant

◼ ◼

Endocanabinoid antagonist - newest agent Contraindicated in depression

36
Q

Side effect of metformin

A

Weight reducing
GI upset
Nausea & vomiting

37
Q

Statins

Mechanism of action

A

Statins work by inhibiting the HMG~CoA reductase enzyme in the liver which would normally be used in the production of cholesterol. Decrease in the plasma concentration of cholesterol causes an increase in the number of LDL receptors, which in turn increases the rate of LDL removal from the plasma.

Secondary importance of statins appear to be as acting as antiinflammatories, plaque reduction, and reduction in thrombotic risk.

38
Q

Short acting statins give examples
شوكت ننطي مثل هيج نوع من الأدوية
وكذلك شنو الفرق عن ال longer half life

A

Short acting statins, such as simvastatin, can have t 1 / 2 of 1-4 hours and are usually given at night to coincide with peak cholesterol production in the early morning.

Others have t 1 / 2 of around 20 hours so can be given at any time of day and have superior efficacy. Statins will show a non-linear pharmacokinetics.

39
Q

Adverse Drug Reactions of statins

A

Statins appear to be well tolerated by the general population. The only significant ADRs seen involve increased transaminase levels and myopathies (more common with increasing age, can be checked by testing the CPK levels), yet only seen in 0.1% of individuals who take high doses. Other miscellaneous complaints reported include GI complaints, joint pain, and headaches.

40
Q

Cholesterol Absorption Inhibitors

A

Cholesterol Absorption Inhibitors act by blocking the specific cholesterol transport protein NPC1L1 in the brush border. This causes a reduction in the amount of dietary cholesterol reaching the liver, which in turn causes a secondary upregulation of LDL transporter expression. Both of these combine to cause a lowered circulating cholesterol level

41
Q

Cholesterol Absorption Inhibitors give examples

A

Ezetimibe can reduce LDL levels by around 15-20% and is normally given as a monotherapy is statin-intolerant patients; if used synergistically with statins, it can cause a 20% reduction in LDL levels (which is actually better than simply doubling the dose of a statin as it reduces the ADRs of the statin).

42
Q

Fibrates

يستخدم بشكل رئيسي لتخفيض ؟

A

Fibrates act on the Peroxisome Proliferator-Activated Receptor-α (PPARα), which acts to significantly reduce triglyceride production, and also lowers LDL and raises HDL. Whilst they can be used in conjunction with statins, they are mainly used directly for hypertriglyceraemias.

43
Q

Fibrates C.I.

A

They are not to be used with hepatic or renal dysfunction, as well as any pre-existing gall-bladder disease due to risk of cholelithiasis.

44
Q

Nicotine’s acid give example

A

Niacin
Inhibit hormone sensitive lipase in the adipose tissue so decreasing the levels of free fatty acids synthesized in adipose tissue & decreasing levels of free fatty acids reaching the liver which lead to decrease VLDL & LDL

45
Q

Bile acids sequestrants

Mechanism of action

A

these drugs lead to increase excretion of bile acids by formation of insoluble complexes which lead to to increase synthesis of bile acids which made of cholesterol lead to increase expression of LDL receptors hence lowering LDL levels

46
Q

Bile acid sequestrants

Give examples of

A

Colesevelan
Colestipol
Cholestyramin

47
Q

Fibrates give examples

A

Fenofibrate

Gemfibrozil

48
Q

Omega 3 fatty acids give examples

A

DHA & EPA

Icosapent ethyl

49
Q

Omega 3 fatty acids mechanism of action

A

Inhibit VLDL &TG synthesis in the liver

50
Q

PCSK9 INHIBITORS

Give examples

A

Evolocumab

Alirocumab

51
Q

PCSK9 inhibitors

ميكانيزم

A

هذا أنزيم يكسر ال LDL رسبتورز فبالتالي مراح يبقى ريسبتور فهذا راح يثبطه ويبين الرسبترات لوقت اطول فيقل ال LDL